You may also like

Microbiome-based Drug Development: Bernat Olle on The Long Run
The MIT Biotech Group Alumni: Where Are They Now?
A One-Bug Drug For the Immune System? Evelo Gets $50M to Test Concept
It’s Time to Re-Think How We Train and Develop Biomedical Scientists